Bystolic (Carilion Materials Management)


Welcome to the PulseAid listing for the Bystolic drug offered from Carilion Materials Management. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Carilion Materials Management
NON-PROPRIETARY NAME: nebivolol hydrochloride
SUBSTANCE NAME: NEBIVOLOL HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2008-01-22
END MARKETING DATE: 0000-00-00


Bystolic HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBystolic from Carilion Materials Management
LABELER NAME: Carilion Materials Management
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/1)
START MARKETING DATE: 2008-01-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68151-5135_ca39c719-336a-437e-b7d2-98bb32ecd619
PRODUCT NDC: 68151-5135
APPLICATION NUMBER: NDA021742

Other NEBIVOLOL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Allergan USA, Inc.Bystolic
Amerigen Pharmaceuticals Inc.Nebivolol
Avera McKennan HospitalBystolic
Cardinal HealthBystolic
Carilion Materials ManagementBystolic
Physicians Total Care, Inc.Bystolic